1. Home
  2. CRK vs PBLS Comparison

CRK vs PBLS Comparison

Compare CRK & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Resources Inc.

CRK

Comstock Resources Inc.

N/A

Current Price

$13.73

Market Cap

4.1B

Sector

Energy

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$40.44

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRK
PBLS
Founded
1983
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.6B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
CRK
PBLS
Price
$13.73
$40.44
Analyst Decision
Hold
Analyst Count
10
0
Target Price
$22.20
N/A
AVG Volume (30 Days)
2.2M
351.8K
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
288.16
N/A
EPS
0.40
N/A
Revenue
$555,231,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.91
N/A
P/E Ratio
$33.85
N/A
Revenue Growth
32.11
N/A
52 Week Low
$12.12
$25.56
52 Week High
$28.10
$41.35

Technical Indicators

Market Signals
Indicator
CRK
PBLS
Relative Strength Index (RSI) 52.82 71.58
Support Level $12.56 $34.78
Resistance Level $14.25 N/A
Average True Range (ATR) 0.52 2.45
MACD 0.04 0.45
Stochastic Oscillator 58.90 92.65

Price Performance

Historical Comparison
CRK
PBLS

About CRK Comstock Resources Inc.

Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. The company's oil and gas operations are concentrated in Louisiana and Texas.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: